Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 19 | $53,878,937 |
| Sells | 105 | $35,549,260 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Oct 2024 17:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Oct 2024 | Sale | 274 | 66.6 | 18,248 | D |
| 31 Oct 2024 17:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Oct 2024 | Sale | 2,154 | 66.6 | 143,456 | D |
| 18 Sep 2024 16:28 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 Sep 2024 | Sale | 10,501 | 37.59 | 394,733 | D |
| 18 Sep 2024 16:26 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 16 Sep 2024 | Sale | 2,635 | 37.59 | 99,050 | D |
| 11 Sep 2024 20:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 09 Sep 2024 | Sale | 895 | 33.33 | 29,830 | D |
| 11 Sep 2024 20:10 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 09 Sep 2024 | Sale | 3,639 | 33.33 | 121,288 | D |
| 04 Sep 2024 20:10 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 03 Sep 2024 | Sale | 262 | 31.7096 | 8,308 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 19 Aug 2024 | Sale | 50,000 | 34.4904 | 1,724,520 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 16 Aug 2024 | Sale | 50,000 | 34.297 | 1,714,850 | D |
| 19 Aug 2024 17:23 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 15 Aug 2024 | Sale | 39,824 | 33.0832 | 1,317,505 | D |
| 14 Aug 2024 16:50 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 12 Aug 2024 | Sale | 59,787 | 33.9507 | 2,029,811 | D |
| 14 Aug 2024 16:50 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 13 Aug 2024 | Sale | 24,987 | 34.7582 | 868,503 | D |
| 08 Aug 2024 17:39 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 08 Aug 2024 | Sale | 100,000 | 31.8238 | 3,182,380 | D |
| 08 Aug 2024 17:39 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 06 Aug 2024 | Sale | 12,994 | 29.3541 | 381,427 | D |
| 02 Aug 2024 16:21 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 31 Jul 2024 | Sale | 88,839 | 33.5027 | 2,976,346 | D |
| 31 Jul 2024 17:03 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 29 Jul 2024 | Sale | 50,000 | 33.8578 | 1,692,890 | D |
| 31 Jul 2024 16:40 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Jul 2024 | Sale | 2,154 | 33.54 | 72,245 | D |
| 31 Jul 2024 16:39 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 274 | 33.54 | 9,190 | D |
| 26 Jul 2024 19:49 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 26 Jul 2024 | Sale | 60,000 | 33.8543 | 2,031,258 | D |
| 26 Jul 2024 19:49 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 24 Jul 2024 | Sale | 75,000 | 33.7214 | 2,529,105 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 23 Jul 2024 | Sale | 75,000 | 33.4566 | 2,509,245 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 22 Jul 2024 | Sale | 50,000 | 32.6088 | 1,630,440 | D |
| 23 Jul 2024 17:16 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 19 Jul 2024 | Sale | 25,000 | 32.29 | 807,250 | D |
| 19 Jul 2024 18:46 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 17 Jul 2024 | Sale | 25,000 | 32.9275 | 823,188 | D |
| 09 Jul 2024 16:07 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 05 Jul 2024 | Sale | 36,118 | 28.2412 | 1,020,016 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 03 Jul 2024 | Sale | 14,082 | 28.2269 | 397,491 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 02 Jul 2024 | Sale | 25,000 | 29.1238 | 728,095 | D |
| 03 Jul 2024 16:56 | WGS | GeneDx Holdings Corp | OPKO HEALTH, INC. | 10% | 01 Jul 2024 | Sale | 50,000 | 26.634 | 1,331,700 | D |
| 18 Jun 2024 17:18 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 17 Jun 2024 | Sale | 2,646 | 28.31 | 74,908 | D |
| 18 Jun 2024 17:17 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 17 Jun 2024 | Sale | 7,683 | 28.31 | 217,506 | D |
| 11 Jun 2024 16:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 10 Jun 2024 | Sale | 895 | 24.92 | 22,303 | D |
| 11 Jun 2024 16:13 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 10 Jun 2024 | Sale | 2,652 | 24.92 | 66,088 | D |
| 05 Jun 2024 20:45 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 04 Jun 2024 | Purchase | 30,000 | 22.5159 | 675,477 | D |
| 05 Jun 2024 20:45 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 03 Jun 2024 | Purchase | 100,000 | 20.8164 | 2,081,640 | D |
| 04 Jun 2024 16:20 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 03 Jun 2024 | Sale | 262 | 20.55 | 5,384 | D |
| 31 May 2024 17:37 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 29 May 2024 | Purchase | 40,000 | 21.0651 | 842,604 | D |
| 28 May 2024 20:40 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 28 May 2024 | Purchase | 18,304 | 20.6057 | 377,167 | D |
| 28 May 2024 20:40 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 24 May 2024 | Purchase | 144,196 | 20.1178 | 2,900,906 | D |
| 28 May 2024 20:40 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 23 May 2024 | Purchase | 7,500 | 19.5888 | 146,916 | D |
| 15 May 2024 18:16 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 13 May 2024 | Purchase | 50,000 | 23.3059 | 1,165,295 | D |
| 30 Apr 2024 16:30 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 29 Apr 2024 | Sale | 6,325 | 11.0368 | 69,808 | D |
| 30 Apr 2024 16:27 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 29 Apr 2024 | Sale | 1,104 | 11.0368 | 12,185 | D |
| 19 Mar 2024 16:15 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | CHIEF EXECUTIVE OFFICER | 18 Mar 2024 | Sale | 8,559 | 10.5925 | 90,661 | D |
| 19 Mar 2024 16:14 | WGS | GeneDx Holdings Corp | SAAD KAREEM | CHIEF TRANSFORMATION OFFICER | 18 Mar 2024 | Sale | 2,008 | 10.5923 | 21,269 | D |
| 19 Mar 2024 16:14 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 18 Mar 2024 | Sale | 3,253 | 10.5917 | 34,455 | D |
| 13 Mar 2024 16:28 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 12 Mar 2024 | Sale | 931 | 9.2097 | 8,574 | D |
| 13 Mar 2024 16:24 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | CHIEF EXECUTIVE OFFICER | 12 Mar 2024 | Sale | 2,618 | 9.2097 | 24,111 | D |
| 13 Mar 2024 16:22 | WGS | GeneDx Holdings Corp | SAAD KAREEM | CHIEF TRANSFORMATION OFFICER | 12 Mar 2024 | Sale | 897 | 9.2095 | 8,261 | D |
| 06 Mar 2024 19:32 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 05 Mar 2024 | Purchase | 900 | 8.827 | 7,944 | D |
| 06 Mar 2024 19:32 | WGS | GeneDx Holdings Corp | CASDIN CAPITAL, LLC | Director , 10% | 04 Mar 2024 | Purchase | 40,000 | 8.7427 | 349,708 | D |
| 05 Mar 2024 16:33 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | CHIEF FINANCIAL OFFICER | 04 Mar 2024 | Sale | 301 | 8.57 | 2,580 | D |
| 23 Jan 2024 16:10 | WGS | GeneDx Holdings Corp | SAAD KAREEM | CHIEF TRANSFORMATION OFFICER | 22 Jan 2024 | Sale | 193 | 3.24 | 625 | D |
| 04 Jan 2024 17:03 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 03 Jan 2024 | Sale | 105 | 2.5799 | 271 | D |
| 19 Dec 2023 21:26 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Dec 2023 | Sale | 11,734 | 2.1594 | 25,338 | D |
| 19 Dec 2023 21:25 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 18 Dec 2023 | Sale | 1,700 | 2.1594 | 3,671 | D |
| 19 Dec 2023 21:24 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 18 Dec 2023 | Sale | 2,948 | 2.1594 | 6,366 | D |
| 12 Dec 2023 16:06 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 11 Dec 2023 | Sale | 3,673 | 1.6104 | 5,915 | D |
| 12 Dec 2023 16:05 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 11 Dec 2023 | Sale | 850 | 1.6104 | 1,369 | D |
| 12 Dec 2023 16:04 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 11 Dec 2023 | Sale | 908 | 1.6104 | 1,462 | D |
| 05 Dec 2023 16:45 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 04 Dec 2023 | Sale | 270 | 1.7693 | 478 | D |
| 20 Nov 2023 16:32 | WGS | GeneDx Holdings Corp | RYAN JASON | Executive Chairman | 17 Nov 2023 | Purchase | 58,000 | 1.5376 | 89,181 | I |
| 20 Nov 2023 16:32 | WGS | GeneDx Holdings Corp | RYAN JASON | Executive Chairman | 16 Nov 2023 | Purchase | 56,742 | 1.2722 | 72,187 | I |
| 17 Nov 2023 16:18 | WGS | GeneDx Holdings Corp | MEISTER KEITH A. | Director , 10% | 15 Nov 2023 | Sale | 883,742 | 1.29 | 1,140,027 | I |
| 08 Nov 2023 19:19 | WGS | GeneDx Holdings Corp | PFENNIGER RICHARD C JR | Director | 08 Nov 2023 | Purchase | 10,000 | 1.4889 | 14,889 | D |
| 23 Oct 2023 17:52 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 20 Oct 2023 | Sale | 164 | 3.44 | 564 | D |
| 18 Oct 2023 16:59 | WGS | GeneDx Holdings Corp | RYAN JASON | Executive Chairman | 17 Oct 2023 | Sale | 42 | 3.19 | 134 | D |
| 03 Oct 2023 16:19 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 03 Oct 2023 | Sale | 85 | 3.5607 | 303 | D |
| 19 Sep 2023 18:09 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 18 Sep 2023 | Sale | 10,752 | 4.1619 | 44,749 | D |
| 19 Sep 2023 18:08 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 18 Sep 2023 | Sale | 1,580 | 4.1617 | 6,575 | D |
| 19 Sep 2023 18:08 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 18 Sep 2023 | Sale | 2,742 | 4.161 | 11,409 | D |
| 12 Sep 2023 18:42 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 11 Sep 2023 | Sale | 2,675 | 4.624 | 12,369 | D |
| 12 Sep 2023 18:41 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 11 Sep 2023 | Sale | 846 | 4.624 | 3,912 | D |
| 12 Sep 2023 18:40 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 11 Sep 2023 | Sale | 904 | 4.624 | 4,180 | D |
| 06 Sep 2023 16:56 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 05 Sep 2023 | Sale | 269 | 4.3797 | 1,178 | D |
| 18 Aug 2023 17:10 | WGS | GeneDx Holdings Corp | PFENNIGER RICHARD C JR | Director | 17 Aug 2023 | Purchase | 5,000 | 5.1046 | 25,523 | D |
| 27 Jul 2023 16:12 | WGS | GeneDx Holdings Corp | WHITE KAREN ANN | Chief People Officer | 26 Jul 2023 | Sale | 61 | 7.41 | 452 | D |
| 21 Jul 2023 21:58 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 20 Jul 2023 | Sale | 163 | 7.85 | 1,280 | D |
| 05 Jul 2023 17:18 | WGS | GeneDx Holdings Corp | WHITE KAREN ANN | Chief People Officer | 03 Jul 2023 | Sale | 45 | 5.99 | 270 | D |
| 05 Jul 2023 17:16 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 03 Jul 2023 | Sale | 83 | 5.99 | 497 | D |
| 21 Jun 2023 16:06 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 20 Jun 2023 | Sale | 107 | 6.3038 | 675 | D |
| 21 Jun 2023 16:06 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 20 Jun 2023 | Sale | 2,637 | 6.3703 | 16,798 | D |
| 21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 20 Jun 2023 | Sale | 311 | 6.33 | 1,969 | D |
| 21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 20 Jun 2023 | Sale | 7,654 | 6.3703 | 48,758 | D |
| 21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | WHITE KAREN ANN | Chief People Officer | 20 Jun 2023 | Sale | 61 | 6.33 | 386 | D |
| 21 Jun 2023 16:05 | WGS | GeneDx Holdings Corp | WHITE KAREN ANN | Chief People Officer | 20 Jun 2023 | Sale | 1,488 | 6.3703 | 9,479 | D |
| 21 Jun 2023 16:04 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 20 Jun 2023 | Sale | 62 | 6.31 | 391 | D |
| 21 Jun 2023 16:04 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 20 Jun 2023 | Sale | 1,159 | 6.3703 | 7,383 | D |
| 13 Jun 2023 17:25 | WGS | GeneDx Holdings Corp | WHITE KAREN ANN | Chief People Officer | 12 Jun 2023 | Sale | 828 | 6.4898 | 5,374 | D |
| 13 Jun 2023 17:23 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 12 Jun 2023 | Sale | 2,674 | 6.4898 | 17,354 | D |
| 13 Jun 2023 17:22 | WGS | GeneDx Holdings Corp | SAAD KAREEM | Chief Transformation Officer | 12 Jun 2023 | Sale | 845 | 6.4898 | 5,484 | D |
| 13 Jun 2023 17:19 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 13 Jun 2023 | Sale | 903 | 6.4898 | 5,860 | D |
| 05 Jun 2023 16:42 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 02 Jun 2023 | Sale | 263 | 7 | 1,841 | D |
| 31 May 2023 16:19 | WGS | GeneDx Holdings Corp | RO ISAAC | Former CFO | 05 Jul 2022 | Sale | 2,296 | 1.3187 | 3,028 | D |
| 31 May 2023 16:17 | WGS | GeneDx Holdings Corp | ASSAD SHAWN | Former CAO | 12 Aug 2022 | Sale | 3,166 | 2.17 | 6,870 | D |
| 31 May 2023 16:17 | WGS | GeneDx Holdings Corp | ASSAD SHAWN | Former CAO | 05 Jul 2022 | Sale | 1,497 | 1.3187 | 1,974 | D |
| 22 May 2023 17:03 | WGS | GeneDx Holdings Corp | PRENTICE ANTHONY | Former Chief Product Officer | 05 Jul 2022 | Sale | 1,828 | 1.3187 | 2,411 | D |
| 22 May 2023 16:59 | WGS | GeneDx Holdings Corp | PFENNIGER RICHARD C JR | Director | 18 May 2023 | Purchase | 5,000 | 5.8999 | 29,500 | D |
| 18 May 2023 19:22 | WGS | GeneDx Holdings Corp | FEELEY KEVIN | Chief Financial Officer | 16 May 2023 | Sale | 1,516 | 6.4985 | 9,852 | D |
| 18 May 2023 19:21 | WGS | GeneDx Holdings Corp | STUELAND KATHERINE | Chief Executive Officer | 16 May 2023 | Sale | 8,685 | 6.4985 | 56,439 | D |
| 04 May 2023 20:43 | WGS | GeneDx Holdings Corp | CLARK DANIEL EMMETT | Former Secretary and GC | 05 Jul 2022 | Sale | 1,207 | 1.3187 | 1,592 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)